Prime Medicine to Participate in Upcoming Investor Conferences Oct 7, 2025 08:00AM
Prime Medicine (PRME) PT Lowered to $10 at Chardan Capital Markets, 'Cash Runway Breathing Room' Aug 8, 2025 04:22PM
Prime Medicine (PRME) PT Lowered to $12 at Chardan Capital Markets May 19, 2025 01:12PM
Prime Medicine (PRME) PT Lowered to $16 at Chardan Capital Markets Mar 20, 2025 06:28AM
Prime Medicine to Participate in Upcoming Investor Conferences Aug 28, 2024 08:00AM


Apr 22, 2024 07:45AM Chardan Capital Markets Assumes Prime Medicine (PRME) at Buy
Feb 20, 2024 04:01PM Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Feb 15, 2024 03:52AM Prime Medicine (PRME) Prices Upsized 19.2M Share Offering at $6.25/sh
Feb 14, 2024 11:50PM Prime Medicine Announces Pricing of Upsized Public Offering
Feb 14, 2024 04:05PM Prime Medicine (PRME) Announces Proposed $125M Share Offering
Feb 14, 2024 04:05PM Prime Medicine Announces Proposed Public Offering of Common Stock
Sep 19, 2023 08:00AM Prime Medicine to Present at Upcoming Investor Conferences